| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.28B | 6.07B | 5.72B | 6.05B | 6.89B | 6.15B |
| Gross Profit | 2.22B | 2.03B | 2.01B | 2.44B | 2.83B | 2.39B |
| EBITDA | 1.52B | 1.24B | 1.13B | 1.53B | 2.80B | 1.40B |
| Net Income | 1.05B | 774.80M | -96.90M | 920.70M | 1.63B | 761.60M |
Balance Sheet | ||||||
| Total Assets | 28.44B | 27.01B | 28.93B | 29.76B | 32.69B | 36.50B |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 1.50B | 1.93B | 1.43B | 2.15B | 1.71B |
| Total Debt | 1.62B | 7.55B | 9.04B | 8.56B | 9.71B | 9.12B |
| Total Liabilities | 13.65B | 11.34B | 13.02B | 12.91B | 16.01B | 21.48B |
| Stockholders Equity | 14.01B | 14.56B | 14.60B | 15.21B | 15.50B | 14.36B |
Cash Flow | ||||||
| Free Cash Flow | 1.37B | 1.12B | 1.14B | 510.30M | 969.30M | 1.12B |
| Operating Cash Flow | 1.39B | 1.19B | 1.30B | 703.20M | 1.08B | 1.23B |
| Investing Cash Flow | -639.10M | 68.40M | -244.30M | -375.60M | -847.90M | -859.60M |
| Financing Cash Flow | -898.10M | -1.66B | -585.40M | -966.90M | 117.30M | -285.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $10.71B | 16.04 | 29.38% | 1.18% | 9.33% | 33.17% | |
78 Outperform | $7.17B | 14.10 | 11.10% | 3.34% | 14.48% | 34.97% | |
77 Outperform | $12.32B | 19.19 | 7.29% | 3.08% | 6.64% | ― | |
74 Outperform | $8.66B | 18.76 | 15.95% | 0.01% | 1.08% | 8.24% | |
74 Outperform | $13.10B | 27.91 | 3.84% | 5.33% | 2.31% | 5.71% | |
73 Outperform | $3.55B | 12.65 | 19.77% | 8.93% | ― | -12.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On December 8, 2025, Invesco Ltd. entered into an agreement with Massachusetts Mutual Life Insurance Company to repurchase $500 million of its 5.9% Fixed Rate Non-Cumulative Perpetual Series A Preference Shares at an 18% premium. The repurchase is expected to close by mid-December 2025, with MassMutual maintaining a significant stake in Invesco. The dividend for the fourth quarter of 2025 will be prorated and reflected in the first quarter 2026 dividend.
The most recent analyst rating on (IVZ) stock is a Buy with a $33.50 price target. To see the full list of analyst forecasts on Invesco stock, see the IVZ Stock Forecast page.